BCL2A1 and cancer: In addition, molecular docking studies suggest that cytotoxic effects may be explained by the affinity of these compounds for the five proteins used as targets and associated with different cancer processes including topoisomerase IIα (TIIα), topoisomerase IIβ (TIIβ) dihydrofolate reductase (DHFR), tetrahydrofolate synthase (MTHFD), and Bcl-2-related protein A1 (BCL-2).